Cancer is a complex disease that evades the immune system through various mechanisms. The rapid proliferation of cells and their ability to resist therapy make cancer extremely aggressive. Solid ...

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.

Dear Dr. Roach: Would you please discuss the meaning and significance of blood tests to show the level of cancer markers to identify cancer and track the efficacy of treatments? I am 69 years old and ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

Doctors often monitor tumor markers in the blood to help diagnose and treat liver cancer. Alpha-fetoprotein (AFP) is the most common tumor marker that doctors monitor. Tumor markers, also called ...

Tumors are heterogenous masses of cells that rapidly divide. Many cells have different mutations, functions, and ways to avoid immune cell detection and drive tumor progression. The heterogeneity of ...

CGP identifies TP53 and SMAD4 mutations as negative prognostic markers, while PTEN mutations correlate with improved survival in CRC patients. Despite no significant survival advantage, CGP-guided ...

Karyotype analysis includes complete chromosome analysis of at least twenty metaphases with at least two cut karyotypes. The presence or absence of an acquired clonal chromosomal abnormality may aid ...

When Christopher Klebanoff, MD, came to Memorial Sloan Kettering Cancer Center (MSK) from the National Cancer Institute in 2016, he was focused on a singular goal: bringing the promise of cellular ...

Researchers developed a liquid biopsy method that improved detection of live circulating tumor cells in triple negative ...